Related Experiment Video

Updated: Aug 7, 2026

Therapeutic Gene Delivery and Transfection in Human Pancreatic Cancer Cells using Epidermal Growth Factor Receptor-targeted Gelatin Nanoparticles
08:35

Therapeutic Gene Delivery and Transfection in Human Pancreatic Cancer Cells using Epidermal Growth Factor Receptor-targeted Gelatin Nanoparticles

Published on: January 4, 2012

INGN 201 (Advexin): adenoviral p53 gene therapy for cancer

Dmitry I Gabrilovich1

  • 1University of South Florida, H. Lee Moffitt Cancer Center and the Department of Interdisciplinary Oncology, MRC 2067, 12902 Magnolia Dr., Tampa, FL 33612, USA. dgabril@moffitt.usf.edu

Expert Opinion on Biological Therapy
|July 22, 2006
PubMed

Insights

Mutations in the p53 gene are common in cancer. Adenoviral p53 gene therapy (Advexin) shows promise as a safe and effective cancer treatment, even in immunotherapy.

Area of Science:

  • Oncology
  • Molecular Biology
  • Gene Therapy

Background:

  • p53 gene mutations are prevalent in ~50% of human cancers.
  • The p53 protein is crucial for DNA damage response and maintaining genetic stability.
  • p53 pathway alterations significantly elevate cancer risk.

Purpose of the Study:

  • To evaluate the safety and efficacy of adenoviral p53 gene therapy (Advexin) as a cancer treatment.
  • To explore Advexin's potential as monotherapy and in combination with other cancer treatments.
  • To assess Advexin's role in cancer immunotherapy.

Main Methods:

  • Preclinical and clinical trials of INGN 201 (Ad5CMV-p53, Advexin), a replication-impaired adenoviral vector.
  • Evaluation of Advexin as a standalone treatment and in conjunction with radiation and chemotherapy.
  • Investigation of Advexin's immunotherapeutic potential.

Main Results:

  • Advexin demonstrated good tolerability in patients.
  • Advexin proved efficacious across various cancer types.
  • Evidence supports Advexin's utility in cancer immunotherapy.

Conclusions:

  • Adenoviral p53 gene therapy (Advexin) is a safe and effective treatment option for diverse cancers.
  • Advexin shows potential as a combination therapy and in cancer immunotherapy.
  • Targeting the p53 pathway offers a promising strategy for cancer treatment.

More Related Videos

Yeast As a Chassis for Developing Functional Assays to Study Human P5314:57

Yeast As a Chassis for Developing Functional Assays to Study Human P53

Published on: August 4, 2019

Live Cell Imaging of the TGF- β/Smad3 Signaling Pathway In Vitro and In Vivo Using an Adenovirus Reporter System11:06

Live Cell Imaging of the TGF- β/Smad3 Signaling Pathway In Vitro and In Vivo Using an Adenovirus Reporter System

Published on: July 30, 2018

Related Concept Videos

Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...